公司资料
Q32 Bio Inc 股价、新闻与催化剂
- 股票代码:
- QTTB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.85 USD (-1.34%)
收盘价
最后更新: 2026年11月5日
214M USD
市值
股价为何变动
截至 2026年11月5日，QTTB 下跌 1.34%，收于 $8.85。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Q32 Bio is a biotechnology company focused on inflammation and immune modulation through complement or related pathways. Its story is built around targeting hard immune-mediated diseases with a specific biological mechanism.
所在地与行业分类
Q32 Bio is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
商业模式特征
The company depends on clinical validation, translational progress, and the ability to keep a narrow pipeline funded. Investors usually watch early data and strategic changes.
生物医药行业定位
Q32 occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs proof that the pathway can create real clinical differentiation.
未来催化剂
- Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform. The company still needs each clinical step to show that the IL-7Rα story is moving from a promising signal into a durable immune-disease franchise.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。